Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
|
Expensive Rocket
3408.8000
-12.60
(
-0.37
%)
NSE
Jul 14, 2026
15:31 PM
Near 52W High of ₹3506.90
Volume:
89,241
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
29 Jul 2025
3408.80
-0.37%
Ajanta Pharma (HOLD): Double-digit growth to continue; EBITDA margin constant
Hold:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 2783 | Target met
Target
BOB Capital Markets Ltd.
Earnings were in line with our estimates with sales /EBITDA/PAT reported 1%/-2.7%/3% above estimates
Ajanta Pharma has gained
28.81%
in the last 1 Year
More from Ajanta Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - July 14, 2026
The Baseline |
14 Jul 2026, 04:56PM
Market closes lower amid renewed West Asia tensions
Trendlyne Marketwatch |
14 Jul 2026, 04:02PM
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017